NEW YORK (GenomeWeb News) – Oxford Gene Technology has formed a scientific advisory board that will include Peter Rigby, who will serve as the board's chair, Jorge Reis-Filho, Martin Bobrow, and Chris Holmes.
Rigby is emeritus professor of developmental biology at the Institute of Cancer Research and deputy chairman of the Board of Governors at the Wellcome Trust. Reis-Filho is a professor of molecular pathology at ICR, and soon will join the Memorial Sloan-Kettering Cancer Center. Bobrow formerly was head of medical genetics at Guy's Hospital and he was deputy chairman of Wellcome Trust and of the Nuffield Council on Bioethics. Holmes is a professor of biostatistics at the University of Oxford, head of statistical genetics at the Wellcome Trust Center for Human Genetics, and an elected member of council of the Royal Statistical Society.
Sequenom has appointed Myla Lai-Goldman to its board of directors and to the board's science committee. Lai-Goldman is a managing partner at Personalized Science and CEO of GeneCentric Diagnostics. Previously, she served as executive vice president, chief medical officer, and chief scientific officer at Laboratory Corporation of America.
Aushon BioSystems has appointed Martin Verhoef to be company CEO and to serve on its board of directors. Verhoef takes over the position from company Founder Peter Honkanen, who will assume the post of COO and will continue as a board director.
Verhoef has spent 25 years in the life science research tools and molecular diagnostics business. He formerly was CEO at MiraDx and PrimeraDx, he led Ciphergen's Biosystems Division, and he held senior management jobs at Agilent in Germany and in the US.
Innova Biosciences Limited said this week that Andrew Lane has joined the company as international licensing manager. Innova said that Lane has spent 18 years working in the biotech industry with a range of partners, including university technology transfer offices, IVD companies, and life sciences businesses.
Complete Genomics said in a filing with the US Securities and Exchange Commission this week that Andrew Senyei has resigned from the company's board of directors.
San Diego-based diagnostics startup Mane Cancer Diagnostics has formed its management team. It will be headed by Evan Levine, who will serve as president, CEO, and a company director. Ian Wisenberg will join him as a director and as chief financial officer.
The company has also hired, as consultants, Joan Robbins as chief scientific officer and Mark Erwin as chief business officer.
Levine is currently a managing partner of investment firm Mark Capital. Before that he was CEO of Adventrx Pharmaceuticals. Wisenberg is a founder and managing partner of BioGlobal Consulting Group and BioGlobal Ventures, as well as co-founder and managing director of ChinaBio Capital Partners.
Robbins is currently the senior director of cancer biology at Tocohen and was previously senior vice president and chief scientific officer at Adventrx as well as a researcher at the National Cancer Institute, the Garvin Institute for Medical Research, and the University of California, San Diego. Erwin is senior director of reimbursement and government affairs at Prometheus Laboratories and was previously senior vice president of commercialization at Adventrx.
Baylor College of Medicine Professor Margaret Spitz has been named the recipient of the Association of American Cancer Institute's 2012 Distinguished Scientist Award.
Spitz is a researcher at BCM's Dan L. Duncan Cancer Center in the Cancer Prevention and Population Sciences Program. She joined BCM after a 27-year career at The University of Texas M.D. Anderson Cancer Center, where she chaired the Department of Epidemiology.
The University of Florida has named Patrick Concannon to be director of its Genetics Institute, succeeding Kenneth Burns, who is retiring after almost a decade directing the institute. Concannon will take the reins at the Genetics Institute in the beginning of 2013.
He currently is associate director of the Center for Public Health Genomics at the University of Virginia, and formerly was associate institute director and molecular genetics program director at the Benaroya Research Institute at Virginia Mason in Seattle and an affiliate professor of immunology at the University of Washington.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.